NHS England has finalized and published new arrangements for commissioning cancer medicines - including the use of the Cancer Drugs Fund - addressing some of the concerns voiced during the run-up consultation period by charities, patient groups and the pharma industry.
The new Cancer Drugs Fund will now have clear entry and exit criteria allowing medicines to move in and out...






